| Activation of the Wnt signaling pathway in chronic lymphocytic leukemia D Lu, Y Zhao, R Tawatao, HB Cottam, M Sen, LM Leoni, TJ Kipps, M Corr, ... Proceedings of the National Academy of Sciences 101 (9), 3118-3123, 2004 | 544 | 2004 |
| Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells D Lu, MY Choi, J Yu, JE Castro, TJ Kipps, DA Carson Proceedings of the National Academy of Sciences 108 (32), 13253-13257, 2011 | 443 | 2011 |
| Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a T Fukuda, L Chen, T Endo, L Tang, D Lu, JE Castro, GF Widhopf, ... Proceedings of the National Academy of Sciences 105 (8), 3047-3052, 2008 | 399 | 2008 |
| Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas CS Rhee, M Sen, D Lu, C Wu, L Leoni, J Rubin, M Corr, DA Carson Oncogene 21 (43), 6598-6605, 2002 | 278 | 2002 |
| Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors D Lu, Y Kiriyama, KY Lee, V Giguere Cancer research 61 (18), 6755-6761, 2001 | 251 | 2001 |
| The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells A Fernandez, IJ Huggins, L Perna, D Brafman, D Lu, S Yao, ... Proceedings of the National Academy of Sciences 111 (4), 1409-1414, 2014 | 120 | 2014 |
| The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus L Zhang, H Wu, D Lu, G Li, C Sun, H Song, J Li, T Zhai, L Huang, C Hou, ... Oncogene 32 (46), 5347-5358, 2013 | 118 | 2013 |
| Repression of β-catenin function in malignant cells by nonsteroidal antiinflammatory drugs D Lu, HB Cottam, M Corr, DA Carson Proceedings of the National Academy of Sciences 102 (51), 18567-18571, 2005 | 116 | 2005 |
| Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/β-catenin pathway D Lu, JX Liu, T Endo, H Zhou, S Yao, K Willert, IGH Schmidt-Wolf, ... PloS one 4 (12), e8294, 2009 | 113 | 2009 |
| The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis SK Kolluri, M Corr, SY James, M Bernasconi, D Lu, W Liu, HB Cottam, ... Proceedings of the National Academy of Sciences 102 (7), 2525-2530, 2005 | 103 | 2005 |
| Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis Y Lin, Y Qiu, C Xu, Q Liu, B Peng, GF Kaufmann, X Chen, B Lan, C Wei, ... Journal of the National Cancer Institute 106 (4), dju012, 2014 | 101 | 2014 |
| Wnt signaling inhibitors, and methods for making and using them W Wrasidlo, CH Jamieson, D Carson, TF Molinski, D Lu US Patent 8,304,408, 2012 | 88 | 2012 |
| Repression of β-catenin signaling by PPARγ ligands D Lu, DA Carson European journal of pharmacology 636 (1-3), 198-202, 2010 | 83 | 2010 |
| Identification of the key protein for zinc uptake in Hemophilus influenzae D Lu, B Boyd, CA Lingwood Journal of Biological Chemistry 272 (46), 29033-29038, 1997 | 71 | 1997 |
| Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients Z Bin, Z Guangbo, G Yan, Z Huan, L Desheng, Z Xueguang Journal of Surgical Research 188 (2), 396-403, 2014 | 65 | 2014 |
| Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model Y Kim, M Schmidt, T Endo, D Lu, D Carson, IGH Schmidt-Wolf In Vivo 25 (6), 887-893, 2011 | 54 | 2011 |
| Targeting the Wnt/beta-catenin pathway in multiple myeloma LC Schmeel, FC Schmeel, Y Kim, T Endo, D Lu, IGH Schmidt-Wolf Anticancer research 33 (11), 4719-4726, 2013 | 50 | 2013 |
| Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells S Yu, Z Wang, Z Su, J Song, L Zhou, Q Sun, S Liu, S Li, Y Li, M Wang, ... BMC complementary and alternative medicine 18, 1-8, 2018 | 47 | 2018 |
| Targeting Wnt pathway in lymphoma and myeloma cells M Schmidt, E Sievers, T Endo, D Lu, D Carson, IGH Schmidt‐Wolf British journal of haematology 144 (5), 796-798, 2009 | 46 | 2009 |
| Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARγ M Hedvat, A Jain, DA Carson, LM Leoni, G Huang, S Holden, D Lu, ... Cancer cell 5 (6), 565-574, 2004 | 46 | 2004 |
